Numis Securities Ltd restated their buy rating on shares of Georgia Healthcare Group PLC (LON:GHG) in a research note released on Monday. The brokerage currently has a GBX 355 ($4.39) price target on the stock.

A number of other analysts also recently weighed in on GHG. Jefferies Group restated a buy rating and issued a GBX 280 ($3.47) target price on shares of Georgia Healthcare Group PLC in a report on Monday, July 25th. Investec began coverage on shares of Georgia Healthcare Group PLC in a report on Wednesday, October 5th. They issued a buy rating and a GBX 361 ($4.47) target price on the stock.

Georgia Healthcare Group PLC (LON:GHG) opened at 305.00 on Monday. The company has a 50-day moving average of GBX 296.89 and a 200-day moving average of GBX 262.73. The company’s market capitalization is GBX 390.95 million. Georgia Healthcare Group PLC has a 1-year low of GBX 145.00 and a 1-year high of GBX 350.00.

Georgia Healthcare Group PLC Company Profile

Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.

Receive News & Stock Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related stocks with our FREE daily email newsletter.